Cholestin and preparation method of cholestin
The invention relates to a Chinese herbal compound preparation, and discloses cholestin. The cholestin comprises, by weight, 800-950 parts of functional monascus red powder, 45-60 parts of salvia extracts, 20-30 parts of hawthorn extracts and 20-30 parts of semen cassiae extracts. The invention further discloses a preparation method of the cholestin. The preparation method particularly includes the steps of fermentation cultivation, inactivation processing, extract preparation, dosing and capsule filling. According to the cholestin and the preparation method of the cholestin, through the whole production process (such as cooking sterilization on smashed rice and smashed soybeans in the fermentation cultivation process and inactivation processing on monascus semi-finished products) of strain selection, bacterium cultivation methods (such as monascus seed cultivation under aseptic conditions), temperature regulation and control, fermentation technologies and the like, generation of citrinin in the fermentation process is controlled, and detection of an authority department proves that the content of the citrinin in the functional monascus conforms to international standards..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Europäisches Patentamt - (2020) vom: 28. Sept. Zur Gesamtaufnahme - year:2020 |
|---|
| Sprache: |
Unbestimmt |
|---|
| Beteiligte Personen: |
FENG JIANPING [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), Last update posted on www.epo.org: 2020-09-28, Last updated: 2021-03-11 |
|---|
| Patentnummer: |
CN104257793 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA004407199 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA004407199 | ||
| 003 | DE-627 | ||
| 005 | 20230503184823.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210529s2020 xx |||||o 00| ||und c | ||
| 035 | |a (DE-627)EPA004407199 | ||
| 035 | |a (EPA)CN104257793 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a und | ||
| 100 | 0 | |a FENG JIANPING |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cholestin and preparation method of cholestin |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), Last update posted on www.epo.org: 2020-09-28, Last updated: 2021-03-11 | ||
| 520 | |a The invention relates to a Chinese herbal compound preparation, and discloses cholestin. The cholestin comprises, by weight, 800-950 parts of functional monascus red powder, 45-60 parts of salvia extracts, 20-30 parts of hawthorn extracts and 20-30 parts of semen cassiae extracts. The invention further discloses a preparation method of the cholestin. The preparation method particularly includes the steps of fermentation cultivation, inactivation processing, extract preparation, dosing and capsule filling. According to the cholestin and the preparation method of the cholestin, through the whole production process (such as cooking sterilization on smashed rice and smashed soybeans in the fermentation cultivation process and inactivation processing on monascus semi-finished products) of strain selection, bacterium cultivation methods (such as monascus seed cultivation under aseptic conditions), temperature regulation and control, fermentation technologies and the like, generation of citrinin in the fermentation process is controlled, and detection of an authority department proves that the content of the citrinin in the functional monascus conforms to international standards. | ||
| 650 | 4 | |a A61K | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61P | |
| 650 | 4 | |a 615 | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2020) vom: 28. Sept. |
| 773 | 1 | 8 | |g year:2020 |g day:28 |g month:09 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/searchResults?DB=EPODOC&locale=en_EP&query=CN104257793A |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2020 |b 28 |c 09 |
| 951 | |a AR | ||
| 952 | |j 2020 |b 28 |c 09 | ||